ONCT   $1.435  6.30% Market Closed After Close 1.55 8.01%

Oncternal Therapeutics Inc
Total Cash 21.43M
totalCashPerShare 7.24
EBITDA
Total Debt 235.00K
quickRatio 2.73
currentRatio 2.887
Total Revenue 1.85M
debtToEquity 1.492
Revenue/Share 0.625
ROA -0.6309
ROE -1.18064
grossProfits
freeCashflow -10.94M
operatingCashflow -25.19M
earningsGrowth
revenueGrowth 6.557
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -11.064919
profitMargins 0.0
enterpriseValue -16.96M
forwardPE -0.1395122
floatShares 2.71M
sharesOutstanding 2.96M
sharesShort 17.89K
sharesShortPriorMonth 13.54K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.09%
heldPercentInstitutions 0.16%
Short Ratio help_outline 0.19%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 5.322
Price To Book help_outline 0.27
earningsQuarterlyGrowth
netIncomeToCommon -35.97M
trailingEps -12.18%
forwardEps -10.25%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -3.19 3Q 2024
institutionsCount 30
lastUpdated Oct. 17, 2024, 6:19 a.m.